FineMark National Bank & Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-9,814
Closed -$975K 400
2019
Q3
$975K Sell
9,814
-1,156
-11% -$110K 0.05% 178
2019
Q2
$1.01M Sell
10,970
-40,578
-79% -$3.85M 0.06% 169
2019
Q1
$4.86M Buy
51,548
+5,194
+11% +$454K 0.28% 82
2018
Q4
$2.97M Buy
46,354
+36,675
+379% +$2.71M 0.2% 96
2018
Q3
$866K Sell
9,679
-4,110
-30% -$363K 0.05% 172
2018
Q2
$1.09M Sell
13,789
-1,349
-9% -$112K 0.07% 165
2018
Q1
$1.35M Sell
15,138
-420
-3% -$40.3K 0.09% 141
2017
Q4
$1.62M Buy
15,558
+2,047
+15% +$231K 0.1% 131
2017
Q3
$1.97M Sell
13,511
-253
-2% -$34.5K 0.13% 120
2017
Q2
$1.79M Buy
13,764
+218
+2% +$26.7K 0.13% 122
2017
Q1
$1.69M Buy
13,546
+450
+3% +$53.9K 0.12% 126
2016
Q4
$1.52M Sell
13,096
-166
-1% -$18.5K 0.12% 127
2016
Q3
$1.39M Sell
13,262
-2,218
-14% -$240K 0.15% 130
2016
Q2
$1.53M Sell
15,480
-444
-3% -$45.9K 0.17% 119
2016
Q1
$1.59M Sell
15,924
-315
-2% -$32.4K 0.19% 113
2015
Q4
$1.94M Buy
16,239
+480
+3% +$55.5K 0.23% 108
2015
Q3
$1.71M Buy
15,759
+390
+3% +$48.4K 0.23% 108
2015
Q2
$1.78M Sell
15,369
-1,453
-9% -$166K 0.23% 105
2015
Q1
$1.94M Sell
16,822
-155
-0.9% -$18.5K 0.26% 103
2014
Q4
$1.9M Buy
16,977
+37
+0.2% +$3.9K 0.28% 98
2014
Q3
$1.61M Buy
16,940
+312
+2% +$28.2K 0.26% 108
2014
Q2
$1.43M Sell
16,628
-764
-4% -$58.1K 0.24% 112
2014
Q1
$1.21M Sell
17,392
-3,718
-18% -$294K 0.23% 115
2013
Q4
$1.78M Buy
21,110
+1,316
+7% +$104K 0.37% 74
2013
Q3
$1.52M Buy
19,794
+2,246
+13% +$157K 0.38% 67
2013
Q2
$1.03M Buy
+17,548
New +$1.06M 0.31% 67

Other funds holding CELG

FineMark National Bank & Trust's CELG Position: Q4 2019 in Review

FineMark National Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,814 shares — an estimated $975K sold.

FineMark National Bank & Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.86M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • FineMark National Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • FineMark National Bank & Trust sold 9,814 Celgene Corp shares in Q4 2019, an estimated $975K.
  • FineMark National Bank & Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • FineMark National Bank & Trust's Celgene Corp position peaked at $4.86M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on FineMark National Bank & Trust's 13F filing for Q4 2019, filed 7 Feb 2020.